While drug donations can have a great role in humanitarian relief, they can actually be detrimental when provided with no regard to international standards. This paper aims to provide some insight into problems encountered during the process of pharmaceutical assistance in emergencies. It presents outcomes of a study involving secondary and field based research conducted in post-tsunami Sri Lanka. Lessons learned and some proposals for improvement of quality and management of pharmaceutical donations are discussed in the last part of the paper.